BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23942221)

  • 41. Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach.
    Weiss A; Wong S; Golshan M; Freedman RA; Metzger O; Bellon J; Mittendorf EA; King TA
    Ann Surg Oncol; 2019 Dec; 26(13):4326-4336. PubMed ID: 31562601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
    van Roozendaal LM; Goorts B; Klinkert M; Keymeulen KBMI; De Vries B; Strobbe LJA; Wauters CAP; van Riet YE; Degreef E; Rutgers EJT; Wesseling J; Smidt ML
    Breast Cancer Res Treat; 2016 Apr; 156(3):517-525. PubMed ID: 27083179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adjusted Hospital Sentinel Lymph Node Positivity Rates in Melanoma: A Novel Potential Measure of Quality.
    Kinnier CV; Paruch JL; Dahlke AR; Wayne JD; Benson AB; Winchester DP; Bilimoria KY
    Ann Surg; 2016 Feb; 263(2):392-8. PubMed ID: 26488806
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a Bayesian approach.
    Okamoto T; Yamazaki K; Kanbe M; Kodama H; Omi Y; Kawamata A; Suzuki R; Igari Y; Tanaka R; Iihara M; Ito Y; Sawada T; Nishikawa T; Maki M; Kusakabe K; Mitsuhashi N; Obara T
    Breast Cancer; 2005; 12(3):203-10. PubMed ID: 16110290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
    Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
    Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
    Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750).
    Skarping I; Ellbrant J; Dihge L; Ohlsson M; Huss L; Bendahl PO; Rydén L
    BMC Cancer; 2024 Jan; 24(1):86. PubMed ID: 38229058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
    Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
    Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axillary Lymph Node Burden in Invasive Breast Cancer: A Comparison of the Predictive Value of Ultrasound-Guided Needle Biopsy and Sentinel Lymph Node Biopsy.
    Boone BA; Huynh C; Spangler ML; Sumkin J; Johnson R; McGuire KP; Soran A; Ahrendt GM
    Clin Breast Cancer; 2015 Oct; 15(5):e243-8. PubMed ID: 25922244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic accuracy of sentinel lymph node biopsy in axillary lymph nodes at the early stages of breast cancer.
    Pusina S
    Med Arch; 2013; 67(4):252-5. PubMed ID: 24520746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of sentinel lymph node biopsy prior to axillary lymph node dissection: the role of isolated tumor cells/micrometastases and multifocality/multicentricity-a retrospective study of 1214 breast cancer patients.
    Schröder L; Fricker R; Stein RG; Rink T; Fitz H; Blasius S; Wöckel A; Müller T
    Arch Gynecol Obstet; 2018 Jun; 297(6):1509-1515. PubMed ID: 29594495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
    Berger ER; Bilimoria KY; Kinnier CV; Minami CA; Bethke KP; Hansen NM; Merkow RP; Winchester DP; Yang AD
    J Surg Oncol; 2019 Jan; 119(1):101-108. PubMed ID: 30481371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of sentinel lymph node biopsy for breast cancer by surgeons in the Department of Defense.
    Davis KG; Schriver JP; Waddell B
    Am J Surg; 2002 Aug; 184(2):94-6. PubMed ID: 12169350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes.
    Mathias BJ; Sun J; Sun W; Zhou JM; Fulp WJ; Laronga C; Lee MC; Kiluk JV
    Clin Breast Cancer; 2021 Feb; 21(1):74-79. PubMed ID: 32917535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of sentinel lymph node biopsy in determining the axillary lymph node metastasis.
    Okur O; Sagiroglu J; Kir G; Bulut N; Alimoglu O
    J Cancer Res Ther; 2020; 16(6):1265-1268. PubMed ID: 33342782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology.
    Luini A; Galimberti V; Gatti G; Arnone P; Vento AR; Trifirò G; Viale G; Rotmensz N; Fernandez JR; Gilardi D; Paganelli G
    Breast Cancer Res Treat; 2005 Jan; 89(2):159-63. PubMed ID: 15692758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.